All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Syndicated Loans

Biotech firm Evotec enters Schuldschein market


Evotec, the biotech and healthcare company headquartered in Hamburg, has launched a Schuldschein with a €100m starting target.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree